biotech news today obesity drugs glp-1 The race may have a new contender. π Regeneron reported Phase 3 data showing its drug candidate delivered up to 19.3% weight loss at 48 weeks, approaching the efficacy seen Roche's Genentech vows to expand
Description
Chromatography was performed with an AKTAexplorer 10 S fast protein liquid chromatography (FPLC) system (GE Healthcare Life Sciences)
The increase in GLP-1RA use going forward is expected to have fundamental impacts on broader consumer and commercial behavior
Pre-operative gastric ultrasound in patients at risk of pulmonary aspiration: a prospective observational cohort study
Effects on liver Despite the lack of expression of GIPR (41, 191) and GLP-1R (192, 193) in hepatocytes, both GIP and GLP-1 have indirect effects on hepatic lipid and glucose metabolism (194)
